Thursday, October 3, 2024 at 2-3pm ET                        Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Hepatitis B virus (HBV) is an infection that is transmitted from mother to child at birth or through exposure to infected blood and bodily fluids. Chronic hepatitis B (CHB) is a long-lasting infection that persists in the blood and liver that can lead to liver failure, cirrhosis, hepatocellular carcinoma (HCC), and death. CHB affects over 1 million Americans and disproportionately affects people from racial and ethnic minorities. Although chronic suppressive therapy exists, current limitations to the management of CHB include the inability to eliminate circulating HBV proteins and the risk of HCC completely.

Learning Objectives

By the end of the program, you will be able to:

• Understand CHB and its epidemiology.
• Discuss the burden of CHB.
• Review current management guidelines for CHB.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.